Bilaketaren emaitzak - Weifeng Xu

Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study nork Caiyun Nie, Caiyun Nie, Caiyun Nie, Caiyun Nie, Weifeng Xu, Weifeng Xu, Weifeng Xu, Weifeng Xu, Huifang Lv, Huifang Lv, Huifang Lv, Huifang Lv, Xiaohui Gao, Guofeng Li, Beibei Chen, Beibei Chen, Beibei Chen, Beibei Chen, Jianzheng Wang, Jianzheng Wang, Jianzheng Wang, Jianzheng Wang, Yingjun Liu, Jing Zhao, Jing Zhao, Jing Zhao, Jing Zhao, Yunduan He, Yunduan He, Yunduan He, Yunduan He, Saiqi Wang, Saiqi Wang, Saiqi Wang, Saiqi Wang, Xiaobing Chen, Xiaobing Chen, Xiaobing Chen, Xiaobing Chen

Connect to this object online.

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity nork Xiaojie Chen, Xiaojie Chen, Xiaojie Chen, Long-Fei Mao, Long-Fei Mao, Long-Fei Mao, Siqi Tian, Xueli Tian, Xueqiong Meng, Mu-Kuo Wang, Weifeng Xu, Yue-Ming Li, Kangdong Liu, Kangdong Liu, Zigang Dong, Zigang Dong

Connect to this object online.